Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SLANGERUP DYREKLINIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   9.2% 10.1% 7.8% 7.4% 5.5% 6.9% 16.0% 15.7%   Credit score (0-100)   28 25 31 31 41 34 12 12   Credit rating   BB BB BB BB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   582 622 621 676 661 541 0.0 0.0   EBITDA   333 140 203 123 148 -43.4 0.0 0.0   EBIT   304 112 184 118 138 -73.4 0.0 0.0   Pre-tax profit (PTP)   296.1 113.4 193.1 116.2 131.8 -77.7 0.0 0.0   Net earnings   231.5 59.1 150.3 57.2 103.8 -59.2 0.0 0.0   Pre-tax profit without non-rec. items   296 113 193 116 132 -77.7 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Tangible assets total   42.1 23.6 5.1 48.9 38.9 109 0.0 0.0   Shareholders equity total   233 292 442 500 603 544 419 419   Interest-bearing liabilities   438 93.4 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   803 562 665 596 823 738 419 419   Net Debt   122 -24.4 -279 -174 -261 -139 -419 -419     See the entire balance sheet 1000.0 Volume  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   582 622 621 676 661 541 0.0 0.0   Gross profit growth   51.2% 6.9% -0.1% 8.9% -2.3% -18.1% -100.0% 0.0%   Employees   1 2 0 0 0 0 0 0   Employee growth %   0.0% 100.0% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 -553.5 -513.0 -584.7 0.0 0.0   Balance sheet total (assets)   803 562 665 596 823 738 419 419   Balance sheet change%   36.3% -29.9% 18.2% -10.3% 38.0% -10.3% -43.2% 0.0%   Added value   332.5 140.4 203.0 676.4 656.2 541.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -57 -57 -37 39 -20 40 -109 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   52.3% 18.0% 29.7% 17.4% 20.9% -13.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   45.2% 17.6% 31.7% 18.7% 19.5% -9.4% 0.0% 0.0%   ROI %   53.7% 22.7% 47.0% 25.0% 25.0% -12.8% 0.0% 0.0%   ROE %   197.6% 22.5% 40.9% 12.2% 18.8% -10.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Equity ratio %   29.0% 51.9% 66.5% 83.8% 73.4% 73.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   36.8% -17.4% -137.7% -141.8% -176.3% 320.1% 0.0% 0.0%   Gearing %   188.2% 32.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.9% 2.5% 2.6% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Quick Ratio   1.3 1.9 2.8 5.3 3.4 3.1 0.0 0.0   Current Ratio   1.3 2.0 3.0 5.7 3.6 3.2 0.0 0.0   Cash and cash equivalent   316.1 117.8 279.4 174.2 261.1 138.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   180.8 268.4 437.2 450.7 564.5 435.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   333 70 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   333 70 0 0 0 0 0 0   EBIT / employee   304 56 0 0 0 0 0 0   Net earnings / employee   232 30 0 0 0 0 0 0